129 related articles for article (PubMed ID: 37310065)
81. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
82. Analysis of metastasis and survival between extrahepatic and intrahepatic cholangiocarcinoma: A large population-based study.
Liao P; Cao L; Chen H; Pang SZ
Medicine (Baltimore); 2021 Apr; 100(16):e25635. PubMed ID: 33879742
[TBL] [Abstract][Full Text] [Related]
83. A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis.
Liu P; Ge M; Hu J; Li X; Che L; Sun K; Cheng L; Huang Y; Pilo MG; Cigliano A; Pes GM; Pascale RM; Brozzetti S; Vidili G; Porcu A; Cossu A; Palmieri G; Sini MC; Ribback S; Dombrowski F; Tao J; Calvisi DF; Chen L; Chen X
Hepatology; 2017 Jul; 66(1):167-181. PubMed ID: 28370287
[TBL] [Abstract][Full Text] [Related]
84. Dual targeting of androgen receptor and mTORC1 by salinomycin in prostate cancer.
Mirkheshti N; Park S; Jiang S; Cropper J; Werner SL; Song CS; Chatterjee B
Oncotarget; 2016 Sep; 7(38):62240-62254. PubMed ID: 27557496
[TBL] [Abstract][Full Text] [Related]
85. Aspirin, Statins, Non-aspirin NSAIDs, Metformin, and the Risk of Biliary Cancer: A Swedish Population-Based Cohort Study.
Marcano-Bonilla L; Schleck CD; Harmsen WS; Sadr-Azodi O; Borad MJ; Patel T; Petersen GM; Therneau TM; Roberts LR; Brusselaers N
Cancer Epidemiol Biomarkers Prev; 2022 Apr; 31(4):804-810. PubMed ID: 35086822
[TBL] [Abstract][Full Text] [Related]
86. BRAF V600E-specific immunohistochemistry reveals low mutation rates in biliary tract cancer and restriction to intrahepatic cholangiocarcinoma.
Goeppert B; Frauenschuh L; Renner M; Roessler S; Stenzinger A; Klauschen F; Warth A; Vogel MN; Mehrabi A; Hafezi M; Boehmer K; von Deimling A; Schirmacher P; Weichert W; Capper D
Mod Pathol; 2014 Jul; 27(7):1028-34. PubMed ID: 24309328
[TBL] [Abstract][Full Text] [Related]
87. The pathways of genetic transformation in cholangiocarcinogenesis.
Serafini FM; Radvinsky D
Cancer Genet; 2016 Dec; 209(12):554-558. PubMed ID: 27720541
[TBL] [Abstract][Full Text] [Related]
88. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer.
Nakagawa H; Hayata Y; Yamada T; Kawamura S; Suzuki N; Koike K
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895797
[TBL] [Abstract][Full Text] [Related]
89. Inhibitor of differentiation proteins do not influence prognosis of biliary tract cancer.
Harder J; Müller MJ; Fuchs M; Gumpp V; Schmitt-Graeff A; Fischer R; Frank M; Opitz O; Hasskarl J
World J Gastroenterol; 2013 Dec; 19(48):9334-42. PubMed ID: 24409060
[TBL] [Abstract][Full Text] [Related]
90. Extracellular Glutamate-Induced mTORC1 Activation via the IR/IRS/PI3K/Akt Pathway Enhances the Expansion of Porcine Intestinal Stem Cells.
Zhu M; Qin YC; Gao CQ; Yan HC; Li XG; Wang XQ
J Agric Food Chem; 2019 Aug; 67(34):9510-9521. PubMed ID: 31382738
[TBL] [Abstract][Full Text] [Related]
91. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas.
Lee D; Do IG; Choi K; Sung CO; Jang KT; Choi D; Heo JS; Choi SH; Kim J; Park JY; Cha HJ; Joh JW; Choi KY; Kim DS
Mod Pathol; 2012 Jan; 25(1):131-9. PubMed ID: 21874010
[TBL] [Abstract][Full Text] [Related]
92. Conjugated bile acids promote cholangiocarcinoma cell invasive growth through activation of sphingosine 1-phosphate receptor 2.
Liu R; Zhao R; Zhou X; Liang X; Campbell DJ; Zhang X; Zhang L; Shi R; Wang G; Pandak WM; Sirica AE; Hylemon PB; Zhou H
Hepatology; 2014 Sep; 60(3):908-18. PubMed ID: 24700501
[TBL] [Abstract][Full Text] [Related]
93. Biliary Tract Cancer: Molecular Biology of Precursor Lesions.
Manzano-Núñez F; Prates Tiago Aguilar L; Sempoux C; Lemaigre FP
Semin Liver Dis; 2023 Nov; 43(4):472-484. PubMed ID: 37944999
[TBL] [Abstract][Full Text] [Related]
94. A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich.
Zhang D; Dorman K; Heinrich K; Weiss L; Boukovala M; Haas M; Greif PA; Ziemann F; Beyer G; Roessler D; Goni E; Renz B; D'Haese JG; Kunz WG; Seidensticker M; Corradini S; Niyazi M; Ormanns S; Kumbrink J; Jung A; Mock A; Rudelius M; Klauschen F; Werner J; Mayerle J; von Bergwelt-Baildon M; Boeck S; Heinemann V; Westphalen CB
Target Oncol; 2023 Sep; 18(5):767-776. PubMed ID: 37594677
[TBL] [Abstract][Full Text] [Related]
95. Notch3 drives development and progression of cholangiocarcinoma.
Guest RV; Boulter L; Dwyer BJ; Kendall TJ; Man TY; Minnis-Lyons SE; Lu WY; Robson AJ; Gonzalez SF; Raven A; Wojtacha D; Morton JP; Komuta M; Roskams T; Wigmore SJ; Sansom OJ; Forbes SJ
Proc Natl Acad Sci U S A; 2016 Oct; 113(43):12250-12255. PubMed ID: 27791012
[TBL] [Abstract][Full Text] [Related]
96. Kidney collecting duct cell type composition is regulated by Notch signaling via modulation of mTORC1.
deRiso J; Mukherjee M; Janga M; Simmons A; Kareta M; Tao J; Chandrasekar I; Surendran K
bioRxiv; 2024 Apr; ():. PubMed ID: 38645025
[TBL] [Abstract][Full Text] [Related]
97. Real-Time Fluorescence Imaging to Identify Cholangiocarcinoma in the Extrahepatic Biliary Tree Using an Enzyme-Activatable Probe.
Takahashi R; Ishizawa T; Inagaki Y; Tanaka M; Ogasawara A; Kuriki Y; Fujita K; Kamiya M; Ushiku T; Urano Y; Hasegawa K
Liver Cancer; 2023 Dec; 12(6):590-602. PubMed ID: 38058421
[TBL] [Abstract][Full Text] [Related]
98. Kras-driven heterotopic tumor development from hepatobiliary organoids.
Ochiai M; Yoshihara Y; Maru Y; Matsuura T; Izumiya M; Imai T; Hippo Y
Carcinogenesis; 2019 Sep; 40(9):1142-1152. PubMed ID: 30753336
[TBL] [Abstract][Full Text] [Related]
99. ELF3 suppresses gallbladder cancer development through downregulation of the EREG/EGFR/mTOR complex 1 signalling pathway.
Nakamura T; Nishikawa Y; Shiokawa M; Takeda H; Yokode M; Matsumoto S; Muramoto Y; Ota S; Yoshida H; Okada H; Kuwada T; Marui S; Matsumori T; Maruno T; Uza N; Kodama Y; Hatano E; Seno H
J Pathol; 2023 Sep; 261(1):28-42. PubMed ID: 37345534
[TBL] [Abstract][Full Text] [Related]
100. Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis.
Yoshida H; Shiokawa M; Kuwada T; Muramoto Y; Ota S; Nishikawa Y; Maeda H; Kakiuchi N; Okamoto K; Yamazaki H; Yokode M; Nakamura T; Matsumoto S; Hirano T; Okada H; Marui S; Sogabe Y; Matsumori T; Mima A; Uza N; Eso Y; Takai A; Takahashi K; Ueda Y; Kodama Y; Chiba T; Seno H
J Gastroenterol; 2023 Aug; 58(8):778-789. PubMed ID: 37310456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
